MetaCap

EnerSyn Global (ESYN) vs McKesson (MCK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

McKesson (MCK) has outperformed EnerSyn Global (ESYN) over the past year, gaining 23.5% versus a loss of 26.5%. McKesson is the larger company by market cap ($123.47 billion vs $37.4 million), about 3298.2 times the size. McKesson pays a dividend yielding 0.32%, while EnerSyn Global does not currently pay one.

McKesson converts more of its revenue into profit, with a net margin of 1.2% versus -303.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ESYN-26.49%MCK+23.49%
+83%+19%-45%
Nov 21, 20251 yearNov 20, 2026
ESYN-97.73%MCK+244.44%
+273%+79%-116%
Mar 21, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ESYN versus MCK key metrics
MetricESYNMCK
Share price$1.11$1,069.43
Market cap$37.44M$123.47B
1-day change-0.89%+0.68%
YTD return-25.50%+30.37%
1-year return-26.49%+23.49%
5-year return—+382.57%
P/E ratio (TTM)—27.58
Forward P/E—20.39
EPS (TTM)$-0.58$38.77
Dividend yield0.00%0.32%
Annual dividend$0.00$3.40
Revenue (latest FY)$866.93K$403.43B
Revenue growth (YoY)-30.84%+12.36%
Net income (latest FY)$-2.63M$4.76B
Gross margin53.03%3.61%
Operating margin—1.54%
Net margin-303.44%1.18%
52-week high$2.81$1,121.50
52-week low$0.88$723.68
Distance from 52-week high-60.50%-4.64%
Analyst consensus—buy
Avg. price target upside—+8.57%
Average volume38.17K790.59K
Shares outstanding33.73M115.46M
Employees441,600
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • McKesson is about 3298.2 times larger than EnerSyn Global by market value ($123.47B vs $37.44M).
  • MCK has outperformed ESYN by 50.0 percentage points over the past year.
  • McKesson is more profitable, keeping 1.2 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
  • McKesson grew revenue faster in its latest fiscal year (+12.36% vs -30.84%).

About EnerSyn Global

ESYN stock →

EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.

Health Care · Other Pharmaceuticals · 4 employees

About McKesson

MCK stock →

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Health Care · Other Pharmaceuticals · 41,600 employees

ESYN vs MCK FAQ

Which is bigger, EnerSyn Global or McKesson?

McKesson (MCK) is larger, with a market capitalization of $123.47B compared with $37.44M for EnerSyn Global (ESYN).

Which stock has performed better over the past year, ESYN or MCK?

MCK returned +23.49% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, EnerSyn Global or McKesson?

McKesson pays a dividend yielding 0.32%, while EnerSyn Global does not currently pay a regular dividend.

Are EnerSyn Global and McKesson in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons